朴炯秀 - Kim & Chang IP | 金·张律师事务所

简介

Hyeongsu Park advises clients on mergers & acquisition, technology licensing, and patent strategies and litigation. With his technical background in biomedical engineering and molecular biology, he assists various international and multinational clients including those in pharmaceutical, medical device and biotech industries.

Mr. Park received his J.D. from Harvard Law School. Prior to his legal education, Mr. Park earned his Bachelor's degree in Biological Engineering from Cornell University. He conducted research on a RNA-guided genome engineering (CRISPR/Cas9) system and a DNA-based drug delivery system.

Prior to joining Kim & Chang, he worked at a national IP law firm in the U.S., advising clients on patent prosecution and litigation strategies.

查看全部

人物简介

经历

Kim & Chang (2018, 2021-Current)

Researcher, Bioinfra Life Science, Inc. (2018-2021)

Knobbe, Martens, Olson & Bear LLP (2015-2017)

主要活动查看全部

著述/活动

Patent-Eligible Subject Matter (South Korea), Practical Law Global, Thomson Reuters (Co-author, 2023)
Inventive Step Standard of Korean Patent Law in Relation to Pharmaceutical Invention, 17(3) L. & Tech. 50 (2021)
Determining Punitive Damages for Patent Infringement - Intentional Infringement and Statutory Factors Affecting Punitive Damages, 16(2) L. & Tech. 87 (2020)
Artificial Intelligence and Patent-Eligible Subject Matter Under Korean Patent Law, 15(5) L. & Tech. 18 (2019)
The Legal Battle Around CRISPR Gene-Editing Technology and Its Implications, 36 Biotech. L. Rep. 39 (2017)
What SCOTUS's Refusal To Review Cases on Patent-Eligible Subject Means, MedCity News (January 2017)
Ten Strategies for Aggressively Building a Patent Portfolio, Medical Device and Diagnostics Industry (MD+DI) (November 2016)
The Defend Trade Secrets Act's Implications for Medtech, Medical Device and Diagnostic Industry (MD+DI) (June 2016)
Draft Guideline for the Revised De Novo Classification Process, Harv. J.L. & Tech. Dig. (June 2016)
Taxpayer Data Disclosure for Academic Use in South Korea, 79 Tax Notes Int'l 955 (2015) (Co-authored with Yunjung Song)
Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott, Harv. J.L. & Tech. Dig. (March 2014)